{"id":"gcflu-pre-filled-syringe-inj","safety":{"commonSideEffects":[{"rate":"10–30","effect":"Injection site pain or erythema"},{"rate":"5–15","effect":"Myalgia"},{"rate":"5–10","effect":"Headache"},{"rate":"1–5","effect":"Fever"},{"rate":"5–10","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL4208783","moleculeType":"Small molecule","molecularWeight":"590.67"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated influenza virus antigens that trigger both humoral and cellular immune responses, enabling the body to recognize and neutralize circulating influenza viruses. By priming the immune system against prevalent seasonal flu strains, it reduces infection risk and severity in vaccinated individuals.","oneSentence":"GCFLU is a pre-filled syringe formulation of an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:44.894Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT03657719","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2018-10-01","conditions":"Influenza, Human","enrollment":105},{"nctId":"NCT03357263","phase":"PHASE1","title":"A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2017-11-20","conditions":"Influenza, Human","enrollment":40},{"nctId":"NCT03285997","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2017-09-30","conditions":"Influenza Vaccine","enrollment":260},{"nctId":"NCT02541253","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2015-09","conditions":"Influenza","enrollment":543},{"nctId":"NCT02723812","phase":"PHASE4","title":"Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old","status":"COMPLETED","sponsor":"Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products","startDate":"2015-11","conditions":"Influenza, Human","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"GCFLU Pre-filled Syringe inj.","genericName":"GCFLU Pre-filled Syringe inj.","companyName":"Green Cross Corporation","companyId":"green-cross-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"GCFLU is a pre-filled syringe formulation of an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}